FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Marketing

False or Misleading Xeomin Promotion: FDA

FDA cautions Merz over misleading representations about its Xeomin in a promotional piece featuring celebrity spokesman Nate Berkus.

latest-news-card-1
Human Drugs

Respironics Recalls Garbin Ventilators

Philips Respironics recalls (Class 1) its Garbin Evo ventilators due to the potential for aerosol deposit accumulation on the devices internal flow se...

latest-news-card-1
Human Drugs

Innovative Manufacturing Technologies Comments

Two stakeholder trade associations suggest changes to an FDA strategy document on innovative manufacturing technologies.

latest-news-card-1
FDA General

Trump Taps RFK Jr. as HHS Secretary

President-elect Donald Trump picks controversial FDA critic and vaccine skeptic Robert F. Kennedy Jr. as his secretary for Health and Human Services.

latest-news-card-1
Human Drugs

Boston Scientific Recalls Cryoablation Catheters

Boston Scientific recalls (Class 1) its POLARx and POLARx FIT Cryoablation Balloon Catheters because of atrio-esophageal fistula risks.

latest-news-card-1
Medical Devices

LivaNova Sleep Apnea Device Meets Endpoints

LivaNova says its aura6000 obstructive sleep apnea treatment met the safety and efficacy endpoints in the OSPREY trial in adults.

latest-news-card-1

FDA Needs Inspection Staff Recruitment Plan: GAO

GAO healthcare director Mary Denigan-Macauley says FDA needs a plan and a strategy for recruiting and retaining new facility inspectors.

Medical Devices

FDA Clears GEs Head-Only MRI Device

FDA clears a GE HealthCare 510(k) for its Signa Magnus, a 3.0T high-performance, head-only MRI scanner.

latest-news-card-1
Human Drugs

Require Studies for Prednisolone Eye Drops: DifGen

DifGen asks FDA to require long-term refrigerated stability studies for any generic form of its Prednisolone Ophthalmic Solution 1%.

latest-news-card-1
Human Drugs

Workshop on Patient Experience Data

Federal Register notice: FDA announces a 12/13 virtual public workshop entitled Patient-Focused Drug Development: Workshop to Discuss Methodologic and...